MIRM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.36%

Insider Buying (Last 12 Months): $60,835.95

Insider Selling (Last 12 Months): $13,320,529.08

Mirum Pharmaceuticals Insider Trading History Chart

Mirum Pharmaceuticals Share Price & Price History

^$71.53

▲ +0.54 (0.76%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Mirum Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/12/2025	Eric Bjerkholt	CFO	Sell	9,578	$76.01	$728,023.78	39,945
9/11/2025	Laura Brege	Director	Sell	17,000	$74.40	$1,264,800.00	15,703
8/11/2025	Christopher Peetz	CEO	Sell	40,000	$62.00	$2,480,000.00	138,641
8/7/2025	Christopher Peetz	CEO	Sell	40,000	$55.25	$2,210,000.00	138,641
8/7/2025	Jolanda Howe	SVP	Sell	10,000	$58.00	$580,000.00	2,426
7/3/2025	Jolanda Howe	SVP	Sell	477	$49.08	$23,411.16	2,426
7/2/2025	Jolanda Howe	SVP	Sell	564	$48.25	$27,213.00	2,903
3/17/2025	Christopher Peetz	CEO	Sell	27,279	$44.21	$1,206,004.59	138,641
3/17/2025	Jolanda Howe	SVP	Sell	57,606	$44.35	$2,554,826.10	4,841
3/17/2025	Peter Radovich	COO	Sell	7,879	$44.21	$348,330.59	18,672
3/4/2025	Patrick J. Heron	Director	Buy	1,335	$45.57	$60,835.95	163,643
2/3/2025	Christopher Peetz	CEO	Sell	9,102	$48.22	$438,898.44	115,920
2/3/2025	Jolanda Howe	SVP	Sell	1,064	$48.22	$51,306.08	4,232
2/3/2025	Peter Radovich	COO	Sell	2,627	$48.22	$126,673.94	26,961
1/24/2025	Christopher Peetz	CEO	Sell	6,837	$47.92	$327,629.04	125,022
1/24/2025	Jolanda Howe	SVP	Sell	902	$47.92	$43,223.84	3,524
1/24/2025	Peter Radovich	COO	Sell	3,177	$47.92	$152,241.84	29,588
1/17/2025	Joanne Quan	Insider	Sell	6,969	$45.86	$319,598.34	5,649
1/7/2025	Christopher Peetz	CEO	Sell	7,489	$42.82	$320,678.98	119,359
1/7/2025	Jolanda Howe	SVP	Sell	750	$42.82	$32,115.00	2,926
1/7/2025	Peter Radovich	COO	Sell	1,998	$42.82	$85,554.36	27,015
11/14/2024	Jolanda Howe	SVP	Sell	2,500	$47.10	$117,750.00	2,426
9/18/2024	Patrick J. Heron	Director	Buy	115	$37.40	$4,301.00	162,308
9/6/2024	Patrick J. Heron	Director	Buy	230	$41.58	$9,563.40	162,193
7/2/2024	Jolanda Howe	SVP	Sell	375	$34.00	$12,750.00	2,426
6/24/2024	Pamela Vig	Insider	Sell	30,559	$34.00	$1,039,006.00	27,406
6/5/2024	Saira Ramasastry	Director	Sell	5,000	$25.68	$128,400.00
3/27/2024	Eric Bjerkholt	CFO	Buy	2,000	$24.80	$49,600.00	14,000
3/25/2024	Peter Radovich	COO	Sell	4,303	$25.80	$111,017.40	29,013
3/18/2024	Eric Bjerkholt	CFO	Buy	2,000	$25.80	$51,600.00	12,000
2/2/2024	Jolanda Howe	SVP	Sell	735	$26.19	$19,249.65	1,759
1/8/2024	Christopher Peetz	CEO	Sell	5,209	$28.03	$146,008.27	110,125
1/8/2024	Jolanda Howe	SVP	Sell	528	$28.04	$14,805.12	722
1/8/2024	Lara Longpre	Insider	Sell	1,019	$28.04	$28,572.76	105,254
1/8/2024	Peter Radovich	COO	Sell	1,408	$28.03	$39,466.24	36,485
12/5/2023	Jolanda Howe	SVP	Sell	2,500	$32.40	$81,000.00
9/14/2023	Michael G. Grey	Director	Sell	14,216	$32.00	$454,912.00
9/11/2023	Eric Bjerkholt	CFO	Buy	10,000	$29.65	$296,500.00	10,000
9/11/2023	Patrick J. Heron	Director	Buy	4,687	$30.30	$142,016.10	152,678
8/31/2023	Patrick J. Heron	Director	Buy	147,991	$26.25	$3,884,763.75	147,991
8/25/2023	Jolanda Howe	SVP	Sell	3,459	$26.23	$90,729.57
7/3/2023	Christopher Peetz	CEO	Sell	5,498	$25.65	$141,023.70	115,334
7/3/2023	Jolanda Howe	SVP	Sell	915	$25.65	$23,469.75	3,459
7/3/2023	Lara Longpre	Insider	Sell	1,004	$25.65	$25,752.60	105,839
7/3/2023	Peter Radovich	COO	Sell	1,425	$25.65	$36,551.25	37,675
5/3/2023	Michael G. Grey	Director	Sell	14,608	$28.00	$409,024.00

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

Institutional Buying and Selling by Quarter

Mirum Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2025	Penn Capital Management Company LLC	307,991	$22.63M	1.7%	-10.0%	0.599%
11/21/2025	CIBC Bancorp USA Inc.	4,303	$0.32M	0.0%	N/A	0.008%
11/17/2025	Dark Forest Capital Management LP	10,082	$0.74M	0.0%	-38.8%	0.020%
11/17/2025	PharVision Advisers LLC	3,724	$0.27M	0.2%	N/A	0.007%
11/17/2025	Virtus Advisers LLC	4,000	$0.29M	0.2%	N/A	0.008%
11/17/2025	Voleon Capital Management LP	86,529	$6.34M	0.2%	N/A	0.168%
11/17/2025	Voloridge Investment Management LLC	389,574	$28.56M	0.1%	+2,116.6%	0.758%
11/17/2025	Polar Capital Holdings Plc	820,552	$60.16M	0.3%	-15.8%	1.597%
11/17/2025	Quarry LP	559	$41K	0.0%	N/A	0.001%
11/17/2025	Qube Research & Technologies Ltd	45,052	$3.30M	0.0%	-71.7%	0.088%
11/17/2025	Millennium Management LLC	309,031	$22.66M	0.0%	+7.2%	0.601%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	20,444	$1.50M	0.0%	-20.3%	0.040%
11/17/2025	Jain Global LLC	55,601	$4.08M	0.0%	N/A	0.108%
11/17/2025	Farallon Capital Management LLC	3,000	$0.22M	0.0%	N/A	0.006%
11/17/2025	Eventide Asset Management LLC	2,522,563	$184.92M	3.0%	-4.4%	4.909%
11/17/2025	Brevan Howard Capital Management LP	10,401	$0.76M	0.0%	N/A	0.020%
11/17/2025	Boone Capital Management LLC	535,732	$39.28M	12.9%	-16.5%	1.042%
11/17/2025	Aquatic Capital Management LLC	63,946	$4.69M	0.1%	+73.3%	0.124%
11/17/2025	Algert Global LLC	190,599	$13.97M	0.2%	+19.6%	0.371%
11/14/2025	Schonfeld Strategic Advisors LLC	7,317	$0.54M	0.0%	N/A	0.014%
11/14/2025	Creative Planning	12,744	$0.93M	0.0%	+38.3%	0.025%
11/14/2025	Raymond James Financial Inc.	251,733	$18.46M	0.0%	-5.0%	0.490%
11/14/2025	Man Group plc	3,960	$0.29M	0.0%	-80.0%	0.008%
11/14/2025	California State Teachers Retirement System	33,125	$2.43M	0.0%	-1.3%	0.064%
11/14/2025	Balyasny Asset Management L.P.	317,150	$23.25M	0.0%	N/A	0.617%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	60,699	$4.45M	0.0%	-62.4%	0.118%
11/14/2025	Two Sigma Investments LP	343,126	$25.16M	0.0%	+99.7%	0.668%
11/14/2025	Squarepoint Ops LLC	127,903	$9.38M	0.0%	+599.8%	0.249%
11/14/2025	Wellington Management Group LLP	790,689	$57.97M	0.0%	+566.8%	1.539%
11/14/2025	F m Investments LLC	29,806	$2.19M	0.1%	+4.4%	0.058%
11/14/2025	FORA Capital LLC	5,140	$0.38M	0.1%	N/A	0.010%
11/14/2025	Glenmede Investment Management LP	3,315	$0.24M	0.0%	N/A	0.006%
11/13/2025	Jump Financial LLC	162,100	$11.88M	0.1%	+9.0%	0.315%
11/13/2025	Arrowstreet Capital Limited Partnership	612,318	$44.89M	0.0%	+709.5%	1.192%
11/13/2025	Connor Clark & Lunn Investment Management Ltd.	495,976	$36.36M	0.1%	+17.0%	0.965%
11/13/2025	Capital Fund Management S.A.	36,115	$2.65M	0.0%	+23.4%	0.070%
11/13/2025	RiverPark Advisors LLC	1,655	$0.12M	0.1%	N/A	0.003%
11/13/2025	Mackenzie Financial Corp	3,787	$0.28M	0.0%	N/A	0.007%
11/13/2025	Magnetar Financial LLC	5,736	$0.42M	0.0%	N/A	0.011%
11/13/2025	Legal & General Group Plc	167,230	$12.26M	0.0%	+288.8%	0.325%
11/13/2025	Swiss National Bank	72,000	$5.28M	0.0%	+2.6%	0.140%
11/13/2025	Russell Investments Group Ltd.	278,763	$20.44M	0.0%	+12.5%	0.542%
11/13/2025	Rhenman & Partners Asset Management AB	56,255	$4.12M	0.5%	-14.4%	0.109%
11/13/2025	First Trust Advisors LP	144,248	$10.58M	0.0%	+11.1%	0.281%
11/12/2025	Dimensional Fund Advisors LP	7,018	$0.51M	0.0%	N/A	0.014%
11/12/2025	Legato Capital Management LLC	34,567	$2.53M	0.3%	+8.8%	0.067%
11/12/2025	Teachers Retirement System of The State of Kentucky	14,724	$1.08M	0.0%	N/A	0.029%
11/12/2025	William Blair Investment Management LLC	313,259	$22.97M	0.1%	N/A	0.610%
11/12/2025	Rafferty Asset Management LLC	33,127	$2.43M	0.0%	-11.0%	0.064%
11/12/2025	Quantbot Technologies LP	448	$33K	0.0%	N/A	0.001%
11/12/2025	Erste Asset Management GmbH	250,000	$18.21M	0.2%	-3.8%	0.486%
11/12/2025	Xponance Inc.	3,151	$0.23M	0.0%	N/A	0.006%
11/12/2025	Intech Investment Management LLC	17,188	$1.26M	0.0%	-17.5%	0.033%
11/12/2025	Fox Run Management L.L.C.	3,158	$0.23M	0.0%	N/A	0.006%
11/10/2025	TD Asset Management Inc	15,400	$1.13M	0.0%	N/A	0.030%
11/10/2025	Palumbo Wealth Management LLC	4,242	$0.31M	0.1%	-24.3%	0.008%
11/10/2025	Patient Square Capital LP	104,262	$7.64M	2.0%	-8.1%	0.203%
11/10/2025	Ameritas Investment Partners Inc.	3,372	$0.25M	0.0%	-24.0%	0.007%
11/10/2025	Semanteon Capital Management LP	7,653	$0.56M	0.7%	N/A	0.015%
11/10/2025	China Universal Asset Management Co. Ltd.	8,806	$0.65M	0.1%	-11.5%	0.017%
11/7/2025	CenterBook Partners LP	8,357	$0.61M	0.0%	N/A	0.016%
11/7/2025	NEOS Investment Management LLC	8,957	$0.66M	0.0%	-10.0%	0.017%
11/7/2025	GSA Capital Partners LLP	8,251	$0.61M	0.1%	-69.5%	0.016%
11/7/2025	Vanguard Group Inc.	2,545,369	$186.60M	0.0%	-0.8%	4.953%
11/7/2025	JPMorgan Chase & Co.	100,209	$7.35M	0.0%	-79.1%	0.195%
11/7/2025	State of New Jersey Common Pension Fund D	30,800	$2.26M	0.0%	N/A	0.060%
11/7/2025	PNC Financial Services Group Inc.	1,262	$93K	0.0%	+183.6%	0.002%
11/7/2025	TimesSquare Capital Management LLC	300,649	$22.04M	0.3%	N/A	0.585%
11/6/2025	Caprock Group LLC	4,778	$0.35M	0.0%	N/A	0.010%
11/6/2025	Rhumbline Advisers	59,065	$4.33M	0.0%	-8.6%	0.118%
11/6/2025	Baader Bank Aktiengesellschaft	6,895	$0.50M	0.0%	N/A	0.014%
11/6/2025	Essex Investment Management Co. LLC	113,458	$8.32M	1.3%	+0.6%	0.226%
11/6/2025	Bryce Point Capital LLC	6,319	$0.46M	0.6%	N/A	0.013%
11/6/2025	Profund Advisors LLC	7,576	$0.56M	0.0%	-7.5%	0.015%
11/6/2025	ProShare Advisors LLC	8,692	$0.64M	0.0%	-19.3%	0.017%
11/6/2025	Candriam S.C.A.	403,026	$29.55M	0.2%	+8.0%	0.802%
11/5/2025	MCF Advisors LLC	427	$31K	0.0%	+76.4%	0.001%
11/5/2025	Alps Advisors Inc.	24,023	$1.76M	0.0%	-9.8%	0.048%
11/5/2025	Envestnet Asset Management Inc.	6,802	$0.50M	0.0%	+27.6%	0.014%
11/4/2025	Penserra Capital Management LLC	26,479	$1.94M	0.0%	+242.4%	0.053%
11/4/2025	Allianz Asset Management GmbH	2,800	$0.21M	0.0%	N/A	0.006%
11/4/2025	Jones Financial Companies Lllp	957	$70K	0.0%	+34.0%	0.002%
11/4/2025	Principal Financial Group Inc.	22,440	$1.65M	0.0%	-28.6%	0.045%
11/4/2025	Atle Fund Management AB	93,605	$6.86M	2.7%	-12.4%	0.186%
11/4/2025	Nan Fung Trinity HK Ltd.	156,265	$11.46M	1.1%	+6.5%	0.311%
11/3/2025	AlphaQuest LLC	12,585	$0.92M	0.1%	+28.6%	0.025%
11/3/2025	Arizona State Retirement System	10,984	$0.81M	0.0%	+2.6%	0.022%
11/3/2025	Knights of Columbus Asset Advisors LLC	20,115	$1.48M	0.1%	+4.4%	0.040%
11/3/2025	Hollencrest Capital Management	1,888	$0.14M	0.0%	N/A	0.004%
11/3/2025	New York State Common Retirement Fund	243,387	$17.84M	0.0%	-2.6%	0.484%
11/3/2025	Ballentine Partners LLC	3,580	$0.26M	0.0%	N/A	0.007%
11/3/2025	Federated Hermes Inc.	346,522	$25.40M	0.0%	+0.6%	0.690%
10/31/2025	Y Intercept Hong Kong Ltd	11,025	$0.81M	0.0%	N/A	0.022%
10/30/2025	Teacher Retirement System of Texas	9,083	$0.67M	0.0%	-8.3%	0.018%
10/30/2025	Strs Ohio	12,700	$0.93M	0.0%	+243.2%	0.025%
10/30/2025	Emerald Mutual Fund Advisers Trust	219,038	$16.06M	0.8%	+0.7%	0.436%
10/30/2025	Emerald Advisers LLC	369,600	$27.10M	0.9%	+20.9%	0.736%
10/29/2025	Wealth Enhancement Advisory Services LLC	6,899	$0.51M	0.0%	-41.8%	0.014%
10/29/2025	Oak Ridge Investments LLC	17,758	$1.30M	0.1%	-2.0%	0.035%
10/28/2025	Wolverine Asset Management LLC	10,670	$0.78M	0.0%	N/A	0.021%

Data available starting January 2016

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.

Today's Range

Now: $71.53

$69.86

$71.98

50 Day Range

MA: $71.62

$67.72

$76.19

52 Week Range

Now: $71.53

$36.88

$78.54

Volume

234,164 shs

Average Volume

545,564 shs

Market Capitalization

$3.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top insider investors include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Eric Bjerkholt (CFO)
Peter Radovich (COO)
Pamela Vig (Insider)
Laura Brege (Director)
Joanne Quan (Insider)
Jolanda Howe (SVP)
Saira Ramasastry (Director)
Learn More about top insider investors at Mirum Pharmaceuticals.
Who are the major institutional investors of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 4.95%
Eventide Asset Management LLC — 4.91%
Polar Capital Holdings Plc — 1.60%
Wellington Management Group LLP — 1.54%
Arrowstreet Capital Limited Partnership — 1.19%
Boone Capital Management LLC — 1.04%
Learn More about top institutional investors of Mirum Pharmaceuticals stock.
Which institutional investors are selling Mirum Pharmaceuticals stock?: During the last quarter, MIRM stock was sold by these institutional investors:
JPMorgan Chase & Co.
Polar Capital Holdings Plc
Eventide Asset Management LLC
Qube Research & Technologies Ltd
Boone Capital Management LLC
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Rice Hall James & Associates LLC
Penn Capital Management Company LLC
Within the last year, company insiders that have sold Mirum Pharmaceuticals company stock include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Eric Bjerkholt (CFO)
Peter Radovich (COO)
Pamela Vig (Insider)
Learn More investors selling Mirum Pharmaceuticals stock.
Which institutional investors are buying Mirum Pharmaceuticals stock?: In the last quarter, MIRM stock was bought by institutional investors including:
Wellington Management Group LLP
Arrowstreet Capital Limited Partnership
Voloridge Investment Management LLC
Balyasny Asset Management L.P.
William Blair Investment Management LLC
TimesSquare Capital Management LLC
Two Sigma Investments LP
Legal & General Group Plc
Within the last year, these company insiders have bought Mirum Pharmaceuticals stock:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Learn More investors buying Mirum Pharmaceuticals stock.